Skip to main content

Peer Review reports

From: Design, synthesis, anticancer evaluation and docking studies of novel 2-(1-isonicotinoyl-3-phenyl-1H-pyrazol-4-yl)-3-phenylthiazolidin-4-one derivatives as Aurora-A kinase inhibitors

Original Submission
30 Apr 2022 Submitted Original manuscript
19 May 2022 Reviewed Reviewer Report
15 Jun 2022 Reviewed Reviewer Report
6 Jul 2022 Author responded Author comments - Navidha Aggarwal
Resubmission - Version 2
6 Jul 2022 Submitted Manuscript version 2
Publishing
26 Jul 2022 Editorially accepted
17 Aug 2022 Article published 10.1186/s13065-022-00852-8

You can find further information about peer review here.

Back to article page